IgA nephropathy is an autoimmune disease of the kidneys. It’s associated with several health conditions and is a significant contributor to chronic kidney disease and kidney failure. In the ...
Hosted on MSN20h
Rare Kidney Diseases: Who’s At Risk?Who’s At Risk? While rare kidney diseases can affect anyone, some are more common in certain ethnic groups. IgA nephropathy, for example, is more prevalent in Asian communities, likely due to a mix of ...
News Medical on MSN5d
New protein identified as key to protecting kidneys in diabetic nephropathyThis study is led by Dr. Haisheng Zhou (Department of Biochemistry and Molecular Biology, Anhui Medical University, China) and Dr. Guoling Zhou (Center for Computational Integrative Biology, ...
The following is a summary of “Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy,” published in the ...
The following is a summary of “Associations between depressive and anxiety symptoms and incident kidney failure in patients with diabetic nephropathy,” published in the February 2025 issue of BMC ...
News Medical on MSN4d
New insights into mTOR pathway offer hope for diabetic nephropathy treatmentA newly published study in Genes & Diseases highlights the crucial role of the mammalian target of rapamycin (mTOR) pathway in the progression of diabetic nephropathy (DN) and explores its potential ...
BioCity Biopharma’s selective endothelin receptor type A (ETA) antagonist has reduced excess proteins in the urine of ...
In patients with type 2 diabetes, the risk for chronic kidney disease differed among users of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylurea.
A newly published study in Genes & Diseases highlights the crucial role of the mammalian target of rapamycin (mTOR) pathway ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback